Taken together, the results in models of acute inflammatory arthritis show that the engagement of B1R by sCD13 controls joint swelling and inflammatory cell influx, whether the process is initiated by systemic administration of autoantibodies (serum transfer arthritis) or by local stimulation of innate immune responses (by zymosan or TNF-α). This evidence concerns the gene BDKRB1 and Arthritis.